Viridian Therapeutics, Inc.DE (VRDN) Insider Trading -- Recent Executive & Director Transactions

8 insiders reported 29 Form 4 transactions for Viridian Therapeutics, Inc.DE (VRDN) over the past 18 months (most recent 2026-08-20). Recent activity: Tousignant Jennifer (Chief Legal Officer) Buy 10,000 shares, Tousignant Jennifer (Chief Legal Officer) Sell 10,000 shares, Tousignant Jennifer (Chief Legal Officer) Sell 4,212 shares, Tripuraneni Radhika (Chief Medical Officer) Buy 40,000 shares, Fairmount Healthcare Fund II L.P. (Director) Buy 1.2M shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-08-20Tousignant JenniferChief Legal OfficerBuy10,000$144,100
2026-08-20Tousignant JenniferChief Legal OfficerSell10,000$245,000
2026-08-20Tousignant JenniferChief Legal OfficerSell4,212$103,194
2026-08-18Tripuraneni RadhikaChief Medical OfficerBuy40,000$528,400
2026-05-13Fairmount Healthcare Fund II L.P.DirectorBuy1.2M$20.0M
2026-05-13Fairmount Funds Management LLCDirectorBuy1.2M$20.0M
2026-05-13Fairmount Healthcare Fund II GP LLCDirectorBuy1.2M$20.0M
2026-03-09Harmon SethChief Financial OfficerSell2,031$61,316
2026-03-09Mahoney Stephen F.President and CEOSell7,408$223,648
2026-03-09Tousignant JenniferChief Legal OfficerSell1,675$50,568
2026-03-09Beetham Thomas W.Chief Operating OfficerSell3,048$92,019
2026-03-04Harmon SethChief Financial OfficerSell2,091$61,308
2026-03-04Harmon SethChief Financial OfficerBuy6,267$0
2026-03-04Tousignant JenniferChief Legal OfficerBuy5,169$0
2026-03-04Tousignant JenniferChief Legal OfficerSell1,724$50,548
2026-03-04Beetham Thomas W.Chief Operating OfficerBuy9,409$0
2026-03-04Beetham Thomas W.Chief Operating OfficerSell3,138$92,006
2026-03-04Mahoney Stephen F.President and CEOBuy18,357$0
2026-03-04Mahoney Stephen F.President and CEOSell7,627$223,624
2026-01-02Tousignant JenniferChief Legal OfficerSell2,272$70,796
2025-10-27Fairmount Healthcare Fund II L.P.DirectorBuy454,545$10.0M
2025-10-27Fairmount Funds Management LLCDirectorBuy454,545$10.0M
2025-10-27Fairmount Healthcare Fund II GP LLCDirectorBuy454,545$10.0M
2025-06-11Fairmount Funds Management LLCDirectorBuy1,600$12,480
2025-06-11Fairmount Healthcare Fund II L.P.DirectorBuy1,600$12,480

Source: SEC Form 4 filings · as of 2026-08-20